Myriad Genetics Inc

MYGN

Equity

ISIN null / Valor 338449

NASDAQ (2026-01-30)

USD 5.62+1.44%

Myriad Genetics Inc
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Myriad Genetics Inc. is a company focused on providing high-quality healthcare services and products, with a particular emphasis on genetic testing and personalized medicine. The company's leadership team includes individuals with extensive experience in the healthcare industry, such as Paul J. Diaz, who has a background in managing Fortune 500 healthcare companies. Myriad Genetics also has a strong focus on technology, with individuals like Kevin R. Haas, who has a background in bioinformatics and molecular simulation. Mark Verratti, the chief commercial officer, is responsible for driving enterprise growth and enhancing commercial and marketing capabilities, particularly in the area of mental health services. Overall, Myriad Genetics is dedicated to leveraging technology and innovation to improve healthcare outcomes for patients.

Summarized from source with an LLMView SourceSector: Technology

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-56.5%1Y

-70.8%3Y

-79.6%5Y

Performance

91.9%1Y

66.8%3Y

62.3%5Y

Volatility